Quality as Culture: Why Biotechs Can’t Afford to Get It Wrong
Quality isn’t just a checkbox — it’s a biotech differentiator.
What does “quality” really mean in biotech? And why does it so often get treated as a box to tick instead of a strategic advantage?
In this episode of The Life Science Insider, Sabine Hutchison speaks with Sandra van Loon about the realities of quality in biotech and clinical development. Together, they unpack why quality is more than compliance, what happens when it’s neglected, and how founders and leaders can make it a real driver of trust, execution, and long-term success.
🔹 Topics include: The difference between compliance and true quality Why quality failures cost more than quality systems How biotechs can embed quality early without slowing down Leadership lessons for building patient- and partner-ready organizations
Liked this episode? Get our monthly LinkedIn newsletter directly to your inbox.
Sign up to stay up-to-date with the business of science, industry news, developing trends, and key insights.